The Problem of Borderline Hemoglobin A2 Levels in the Screening for β-Thalassemia Carriers in Sardinia

Publisher： Karger

E-ISSN： 1421-9662|135|4|193-199

ISSN： 0001-5792

Source： Acta Haematologica, Vol.135, Iss.4, 2016-01, pp. : 193-199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Feasibility of Antenatal Screening of β-Thalassemia in Mumbai, India

By  

Acta Haematologica, Vol. 105, Iss. 4, 2001-08 ,pp. : 252-252

Karger

Access to resources Recommend Favorite

Clinical relevance of deferasirox trough levels in β‐thalassemia patients

By  

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 45, Iss. 2, 2018-02 ,pp. : 213-216

John Wiley & Sons Inc

Access to resources Recommend Favorite

Thromboembolism in β-Thalassemia Major

By  

Acta Haematologica, Vol. 100, Iss. 3, 1998-12 ,pp. : 166-166

Karger

Access to resources Recommend Favorite

Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients

By                        

International Journal of Molecular Medicine, Vol. 29, Iss. 6, 2012-01 ,pp. : 974-982

Spandidos Publications

Access to resources Recommend Favorite

Higher Serum Ferritin Levels Correlate with an Increased Risk of Cutaneous Morbidity in Adult Patients with β-Thalassemia: A Single-Center Retrospective Study

By  

Acta Haematologica, Vol. 135, Iss. 2, 2016-0 ,pp. : 124-130

Karger

Access to resources Recommend Favorite